PBH
+0.0 · +0.00%
USD · NYSE

Prestige Brand Holdings Inc(PBH) Stock Analysis | Healthcare

USD --+0.00%
Reward58Moderate
Risk16Low
75%Data
Strong 16% profit margin
Quality Compounder
Market Cap:2.49Bn
ⓘ
Reward Rating
58
Moderate
Reward Assessment
75% data coverage
Top 50% of stocksView factors
ⓘ
Risk Rating
16
Low
Risk Assessment

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on PBH to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for PBH, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $67.80.

What is Prestige Brand Holdings Inc?

, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

PBH · Verdict

Solid reward · low risk

PBH scores well on volatility and cash flow with no major weaknesses flagged in the model.

Based on 88% data coverage

PBH · Verdict

What’s working & what to watch

Strengths 5

  • Volatility95/100

    Top decile vs peers

  • Cash flow87/100

    23% free-cash-flow margin

  • Profitability83/100

    17% net margin · 9% ROE

  • Balance sheet71/100

    Interest covered 7.1×

  • Valuation70/100

    P/E 11.5× · PEG 1.57

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Prestige Brand Holdings Inc?

, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 2.49B, and a P/E ratio of 14.7x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Strong margins and consistent earnings support financial stability.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (58)

The scoring profile indicates moderate reward potential, with profitability and valuation as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Drug Manufacturers - Specialty & Generic names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market Cap2.49B
P/E Ratio14.6975
Dividend YieldN/A
Beta0.327
Insider Activity
12M windowMixed
Shares soldShares bought
0-3months
0
0
3-6months
0
0
6-9months
21,281 shares
$83k
0
9-12months
1719 shares
$43k
0